Eli Lilly stock soars after Q1 earnings as revenue grows 56% on strength of GLP-1 drug sales

By:
On:
URL has been copied successfully!
Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here